“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]
Vaccine developers at the University of Pittsburgh’s Center for Vaccine Research (CVR) have taken a part of the coronavirus involved in COVID-19 infection and attached it to a genetically modified measles vaccine that has been used for many years.1 According to CVR Director Dr. Paul Duprex, “CVR has a mandated role to respond rapidly to […]
Microsoft founder and philanthropist Bill Gates predicted on Mar. 18, 2020 that the first licensed coronavirus vaccines for COVID-19 will be available within 18 months and that health care workers will be among the first to get the shots. Gates co-chairs the Bill & Melinda Gates Foundation, which recently invested $50 million to develop a […]
Greffex, Inc., a privately-held, multinational genetic engineering company headquartered in Houston, Texas has announced that it has completed development of a vaccine for the COVID-19 coronavirus. The vaccine will now proceed to testing in laboratory animals under supervision by the U.S Food and Drug Administration (FDA) and regulatory agencies in China.1 Greffex Got $18.9M from […]
Story Highlights Another attempt to create an effective vaccine against the Human Immunodeficiency Virus (HIV) has been stopped early because it was not found to prevent HIV infection. It is estimated that 1,000 people are newly infected every day in South Africa. HIV virus appears to evade and destroy cells of the immune system and […]
Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]
Story Highlights Researchers at the University of Colorado Boulder say that a vaccine to prevent stress is on the horizon. According to the study, a bacterium found in soil called Mycobacterium vaccae injected into rodents showed that the injections reduced stress in the rodents. The medical literature shows that spending time in nature and handling soil significantly […]
Story Highlights Global pet and animal vaccine manufacturer, Zoetis, has signed an agreement with Texas A & M to develop a new animal vaccine for foot and mouth disease (FMD). Recently agriculture groups have insisted that USDA develop FMD vaccine bank to prepare for a future FMD outbreak among livestock in the U.S., even though […]
Researchers at the University of Pennsylvania recently reported that they are close to developing a herpes simplex virus 2 (HSV-2) vaccine for humans. HSV-2 primarily causes genital herpes and is contracted through forms of sexual contact with a person who has HSV-2. An estimated 14 percent of Americans between the ages of 15 and 49 […]
Representatives from the National Pork Producers Council, the National Milk Producers Federation, the National Corn Growers Association and Iowa State University have urged the U.S. Department of Agriculture (USDA) to quickly establish a foot-and-mouth disease (FMD) vaccine bank.1 FMD is a contagious viral disease. The virus causes illness in cows, pigs, sheep, goats, deer, and […]